Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03293251

Enrollment

Registered

2017-09-26

Start date

2017-08-01

Completion date

2018-12-29

Last updated

2017-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outcomes of Trabeculectomy With MMC

Brief summary

1. determine whether cataract surgery has a major effect on outcomes of trabeculectomy with MMC or not. 2. Success rates of trabeculectomy with MMC in Queen Elizabeth hospital. 3. recurrence rate of uveitis after glaucoma surgery

Detailed description

1. determine different success rates of trabeculectomy with MMC undergone in QE hospital, UK. 2. determine different complications and effect of cataract surgery on the outcome of glaucoma surgery

Interventions

PROCEDURETrabeculectomy with MMC

glaucoma surgeries

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Fesh trabeculectomy surgeries

Exclusion criteria

* recurrent surgeries

Design outcomes

Primary

Measure	Time frame	Description
Success rates	5 year period	IOP less 21 mmHg

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026